Showing results (81-90 of 183) with videos related to
Sort By:
Pageof 19
Mini Reviews in Medicinal Chemistry|April 10, 2010
MDM2 inhibitors for pancreatic cancer therapyAsfar S Azmi, Philip A Philip, Khaldoun Almhanna, et al.Expert Opinion on Therapeutic Targets|December 7, 2017
Rho GTPase effectors and NAD metabolism in cancer immune suppressionMahmoud Chaker, Audrey Minden, Suzie Chen, et al.Haematologica|February 14, 2013
Selective inhibitors of nuclear export for the treatment of non-Hodgkin's lymphomasAsfar S Azmi, Ayad Al-Katib, Amro Aboukameel, et al.Oncology Letters|May 15, 2026
Multi-omics profiling of pancreatic neuroendocrine tumors: Interplay of genomic instability and the tumor microenvironment (Review)Yin Wan, Yingnan Zhang, Philip A Philip, et al.Pharmaceutical Research|February 2, 2010
Resveratrol mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for chemoprevention of cancerS M Hadi, M F Ullah, A S Azmi, et al.Journal of Cellular Physiology|July 19, 2012
Activated K-Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotypeZhiwei Wang, Shadan Ali, Sanjeev Banerjee, et al.Molecular Cancer|June 2, 2021
Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancerMisako Nagasaka, Mohammed Hafiz Uddin, Mohammed Najeeb Al-Hallak, et al.Current Stem Cell Research & Therapy|August 21, 2013
Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressivenessBin Bao, Asfar S Azmi, Yiwei Li, et al.Expert Opinion on Drug Discovery|June 17, 2024
Targeting guanine nucleotide exchange factors for novel cancer drug discoverySahar F Bannoura, Husain Yar Khan, Md Hafiz Uddin, et al.Mutagenesis|June 10, 2009
Plumbagin induces cell death through a copper-redox cycle mechanism in human cancer cellsS Nazeem, Asfar S Azmi, Sarmad Hanif, et al.Pageof 19